Primary negative symptoms in schizophrenic and nonschizophrenic disorders.

被引:2
|
作者
Gerbaldo, H
MullerSiecheneder, F
机构
关键词
D O I
10.1055/s-2007-996389
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We report on a short overview of our work which has examined different definitions of negative syndromes across a broad spectrum of diagnoses. Primary enduring negative symptoms were assessed with the Schedule for Deficit Syndrome (SDS) and with the Scale for Assessment of Negative Symptoms (SANS) in schizophrenic and non-schizophrenic patients. Results suggested that patients with psychotic disorders are in a high-risk group for deficit syndrome. A further study included (in the deficit group) only neuroleptic-free patients without current depression or psychosis. The frequency of primary enduring negative symptoms (PENS) showed no significant difference between schizophrenic and depressive patients. Study three compared primary negative symptoms between schizophrenic and nonschizophrenic patients. There were no significant differences between both groups with regard to the SANS scores. The last study compared primary with secondary negative symptom complexes by means of the SANS. No significant differences could be found. The results suggest that PENS are not specific for schizophrenia. Moreover, further efforts are indicated to grasp ''core'' deficiencies in psychoses with help of new operationalized instruments.
引用
收藏
页码:221 / 227
页数:13
相关论文
共 50 条
  • [41] Dopamine D3 receptor polymorphism in affective and schizophrenic disorders.
    Putzhammer, A
    Rohrmeier, T
    Schoeler, A
    Sartor, H
    Eichhammer, P
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1998, 81 (06): : 498 - 498
  • [42] BEHAVIORAL AND BIOCHEMICAL EFFECTS OF METHYLPHENIDATE INFUSION IN SCHIZOPHRENIC AND NONSCHIZOPHRENIC PATIENTS
    SHARMA, RP
    JAVAID, JI
    PANDEY, GN
    JANICAK, PG
    DAVIS, JM
    SCHIZOPHRENIA RESEARCH, 1991, 4 (03) : 356 - 356
  • [43] SYMPTOMS OF SCHIZOPHRENIC DISORDERS - GERMAN - SULLWOLD,L
    BATTEGAY, R
    PSYCHOLOGIE-SCHWEIZERISCHE ZEITSCHRIFT FUR PSYCHOLOGIE UND IHRE ANDWENDUNGEN, 1978, 37 (04): : 355 - 355
  • [44] Substance use associated disorders. Frequency in patients with schizophrenic and affective psychoses
    Hermle, L.
    Szlak-Rubin, R.
    Taeschner, K. L.
    Peukert, P.
    Batra, A.
    NERVENARZT, 2013, 84 (03): : 315 - 325
  • [45] The long-term outcome of schizophrenic and related disorders. A critical review
    Gross, G
    Huber, G
    NEUROLOGY PSYCHIATRY AND BRAIN RESEARCH, 2000, 8 (03) : 121 - 130
  • [46] O Destiny and disease in mental disorders. With spezial reference to the schizophrenic psychoses
    v Gebsattel
    NERVENARZT, 1937, 10 (09): : 484 - 485
  • [47] 5HTR2A gene polymorphism and negative symptoms in patients with schizophrenia and schizophrenia spectrum disorders.
    Golimbet, VE
    Manandyan, KK
    Abramova, LI
    Orlova, VA
    Kaleda, VG
    Oleichik, IV
    Yurov, YB
    Trubnikov, VI
    MOLECULAR PSYCHIATRY, 1999, 4 : S90 - S90
  • [48] INTERACTION PATTERNS OF PARENTS AND HOSPITALIZED SONS DIAGNOSED AS SCHIZOPHRENIC OR NONSCHIZOPHRENIC
    FARINA, A
    HOLZBERG, JD
    JOURNAL OF ABNORMAL PSYCHOLOGY, 1968, 73 (02) : 114 - &
  • [49] BEHAVIORAL AND BIOCHEMICAL EFFECTS OF METHYLPHENIDATE IN SCHIZOPHRENIC AND NONSCHIZOPHRENIC PATIENTS
    SHARMA, RP
    JAVAID, JI
    PANDEY, GN
    JANICAK, PG
    DAVIS, JM
    BIOLOGICAL PSYCHIATRY, 1991, 30 (05) : 459 - 466
  • [50] A COMPARISON OF CRIMINAL RECIDIVISM AMONG SCHIZOPHRENIC AND NONSCHIZOPHRENIC OFFENDERS
    RICE, ME
    HARRIS, GT
    INTERNATIONAL JOURNAL OF LAW AND PSYCHIATRY, 1992, 15 (04) : 397 - 408